News and Updates

Waxman Strategies Adds Senior Staffers to Expand Health, Technology and Environmental Practices

Waxman Strategies today announced the addition of senior communications professionals as the firm continues to expand its technology, healthcare and environmental practices.

Waxman Strategies Welcomes Seasoned Global Policy Leaders to Environmental Practice

Waxman Strategies Welcomes Seasoned Global Policy Leaders to Environmental Practice. Mat Jacobson and Abdul Tejan-Cole bring a combined 40+ years of global campaign experience to the Waxman team.

Open Enrollment and the Midterms: What to Look Out for Next Week

The sixth annual open enrollment period for the Affordable Care Act kicks off today – and in less than a week, voters will go to the polls, where the future of health policy will be decided. Now more than ever, health care – and how it’s delivered – is top of mind for Americans.

Former Congressman Henry Waxman Provides Guidance to Democrats Anticipating White House Investigations

In the final weeks preceding the 2018 midterm elections, Waxman Strategies’ Chairman and former Congressman Henry Waxman engaged in a series of interviews to elevate the benefits behind bipartisanship and the importance of effecting a credible and comprehensive investigation.

2018 Mid-Term Elections Insights from Waxman Strategies

Today, we are excited to launch the Waxman Strategies Elections Hub, where we are sharing insights into the potential policy scenarios that could play out in November and beyond.

Congress is Making Quiet Progress on Drug Costs

The Commonwealth Fund published a To the Point blog post detailing the incremental steps that Congress has taken on policies that would lower drug costs for patients.

Hatch Amendment Could Delay Generic Drug Competition and Increase Drug Prices

If it passes in Congress, the unfortunately named Hatch-Waxman Integrity Act of 2018 would ultimately delay generic drug competition and increase drug prices.

California Health Care Foundation Interviews Waxman Strategies Chairman Henry Waxman on the Future of Health Policy

California Health Care Foundation (CHCF) interviews  Waxman Strategies Chairman Henry Waxman on the changing political landscape of health care reform.

Former Congress Henry Waxman Speaks About Drug Prices and the Affordable Care Act at Spotlight Health in Aspen, CO

Former Congressman Henry Waxman (D-Calif.) and chairman of Waxman Strategies participated last weekend in the Aspen Institute’s annual Spotlight Health event to talk about rising prescription drug prices, as well as, reminisce on the Affordable Care Act (ACA).

Analyzing the US Food and Drug Administration’s Plans to Increase Competition in Response to High Drug Prices

Prescription drug prices have reached an all-time high. FDA Commissioner Gottlieb has taken on the issue indirectly, and announced several actions by the FDA intended to increase generic drug competition and transparency.